Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates
Biotechnology and Bioengineering · 2023-08 · 120 (8) · 2283-2300
DOI: 10.1002/bit.28495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 12.07.2023. Verfasst von Wenning Chu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Dependovirus, Peptides. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FDA HHS.
Abstract (Originalsprache)
Adeno‐associated viruses (AAVs) are the vector of choice for delivering gene therapies that can cure inherited and acquired diseases. Clinical research on various AAV serotypes significantly increased in recent years alongside regulatory approvals of AAV‐based therapies. The current AAV purification platform hinges on the capture step, for which several affinity resins are commercially available. These adsorbents rely on protein ligands—typically camelid antibodies—that provide high binding capacity and selectivity, but suffer from low biochemical stability and high cost, and impose harsh elution conditions (pH < 3) that can harm the transduction activity of recovered AAVs. Addressing these challenges, this study introduces peptide ligands that selectively capture AAVs and release them under mild conditions (pH = 6.0). The peptide sequences were identified by screening a focused library and modeled in silico against AAV serotypes 2 and 9 (AAV2 and AAV9) to select candidate ligands that target homologous sites at the interface of the VP1‐VP2 and VP2‐VP3 virion proteins with mild binding strength ( K D ~ 10 −5 –10 − 6 M). Selected peptides were conjugated to Toyopearl resin and evaluated via binding studies against AAV2 and AAV9, demonstrating the ability to target both serotypes with values of dynamic binding capacity (DBC 10% > 10 13 vp/mL of resin) and product yields (~50%–80%) on par with commercial adsorbents. The peptide‐based adsorbents were finally utilized to purify AAV2 from a HEK 293 cell lysate, affording high recovery (50%–80%), 80‐ to 400‐fold reduction of host cell proteins (HCPs), and high transduction activity (up to 80%) of the purified viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.
- Biomanufacturing Training and Education Center (BTEC), North Carolina State University, Raleigh, North Carolina, USA.
- North Carolina Viral Vector Initiative in Research and Learning (NC-VVIRAL), North Carolina State University, Raleigh, North Carolina, USA.
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel Hill, Raleigh, North Carolina, USA.
- LigaTrap Technologies LLC, Raleigh, North Carolina, USA.
ORCID-Profile: Wenning Chu, Gary Gilleskie, Stefano Menegatti
Förderung
- FDA HHS
Zitieren
APA
Chu, W., Shastry, S., Barbieri, E., Prodromou, R., Greback-Clarke, P., Smith, W., Moore, B., Kilgore, R., Cummings, C., Pancorbo, J., Gilleskie, G., Daniele, M. A., & Menegatti, S. (2023). Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates. Biotechnology and Bioengineering, 120(8), 2283-2300. https://doi.org/10.1002/bit.28495
Vancouver
Chu W, Shastry S, Barbieri E, Prodromou R, Greback-Clarke P, Smith W, et al. Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates. Biotechnology and Bioengineering. 2023;120(8):2283-2300. doi:10.1002/bit.28495
BibTeX
@article{Chu2023,
author = {Chu, Wenning and Shastry, Shriarjun and Barbieri, Eduardo and Prodromou, Raphael and Greback-Clarke, Paul and Smith, Will and Moore, Brandyn and Kilgore, Ryan and Cummings, Christopher and Pancorbo, Jennifer and Gilleskie, Gary and Daniele, Michael A and Menegatti, Stefano},
title = {Peptide ligands for the affinity purification of adeno‐associated viruses from HEK 293 cell lysates},
journal = {Biotechnology and Bioengineering},
year = {2023},
volume = {120},
number = {8},
pages = {2283--2300},
doi = {10.1002/bit.28495}
}
EUVIMED